TriSalus Life Sciences, Inc.
TLSI · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$30,045 | -$59,363 | -$47,187 | -$28,845 |
| Dep. & Amort. | $744 | $684 | $398 | $464 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $5,441 | $1,402 | $368 | $109 |
| Change in WC | -$9,549 | $537 | $2,300 | -$131 |
| Other Non-Cash | -$7,434 | $6,162 | $11,808 | $5,706 |
| Operating Cash Flow | -$40,843 | -$50,578 | -$32,313 | -$22,697 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$345 | -$588 | -$655 | -$1,097 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | -$1,000 | -$1,131 | -$1,161 |
| Investing Cash Flow | -$345 | -$1,588 | -$1,786 | -$2,258 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $24,916 | -$87 | -$131 | -$1,303 |
| Stock Issued | $15,537 | $0 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$2,517 | $54,716 | $13,593 | $52,071 |
| Financing Cash Flow | $37,936 | $54,629 | $13,462 | $50,768 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$3,252 | $2,463 | -$20,637 | $25,813 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $12,127 | $9,664 | $30,301 | $4,488 |
| End Cash | $8,875 | $12,127 | $9,664 | $30,301 |
| Free Cash Flow | -$41,188 | -$51,166 | -$33,099 | -$23,955 |